DE60117583D1 - Liposomen welche antikanzeröse wirkstoffe verkapseln und deren verwendung zur behandlung von malignen tumoren - Google Patents
Liposomen welche antikanzeröse wirkstoffe verkapseln und deren verwendung zur behandlung von malignen tumorenInfo
- Publication number
- DE60117583D1 DE60117583D1 DE60117583T DE60117583T DE60117583D1 DE 60117583 D1 DE60117583 D1 DE 60117583D1 DE 60117583 T DE60117583 T DE 60117583T DE 60117583 T DE60117583 T DE 60117583T DE 60117583 D1 DE60117583 D1 DE 60117583D1
- Authority
- DE
- Germany
- Prior art keywords
- treatment
- anticanced
- agents
- liposomes
- malignant tumors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000002502 liposome Substances 0.000 title abstract 3
- 206010028980 Neoplasm Diseases 0.000 title 1
- 239000003795 chemical substances by application Substances 0.000 title 1
- 230000003211 malignant effect Effects 0.000 title 1
- 108010038807 Oligopeptides Proteins 0.000 abstract 2
- 102000015636 Oligopeptides Human genes 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 2
- 108010028921 Lipopeptides Proteins 0.000 abstract 1
- 230000001093 anti-cancer Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 238000001990 intravenous administration Methods 0.000 abstract 1
- ZADHKSJXSZBQFB-HHHXNRCGSA-N lipid fragment Chemical compound CC(C)CCCCCCCCCCCC[C@@H](C)CCCCCCCC(C)C ZADHKSJXSZBQFB-HHHXNRCGSA-N 0.000 abstract 1
- 125000006850 spacer group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200002447 | 2000-10-10 | ||
| ES200002447A ES2186484B1 (es) | 2000-10-10 | 2000-10-10 | Liposomas encapsulando farmacos anticancerosos y uso de los mismos en el tratamiento de tumores malignos. |
| PCT/ES2001/000367 WO2002030397A1 (es) | 2000-10-10 | 2001-10-03 | Liposomas encapsulando farmacos anticancerosos y uso de los mismos en el tratamiento de tumores malignos |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE60117583D1 true DE60117583D1 (de) | 2006-04-27 |
| DE60117583T2 DE60117583T2 (de) | 2006-10-05 |
Family
ID=8495226
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60117583T Expired - Lifetime DE60117583T2 (de) | 2000-10-10 | 2001-10-03 | Liposomen welche antikanzeröse wirkstoffe verkapseln und deren verwendung zur behandlung von malignen tumoren |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7153490B2 (de) |
| EP (1) | EP1325739B1 (de) |
| JP (1) | JP4286535B2 (de) |
| AT (1) | ATE318582T1 (de) |
| AU (1) | AU9190401A (de) |
| BR (1) | BR0113552A (de) |
| CA (1) | CA2425271C (de) |
| DE (1) | DE60117583T2 (de) |
| DK (1) | DK1325739T3 (de) |
| ES (2) | ES2186484B1 (de) |
| MX (1) | MXPA03003125A (de) |
| PT (1) | PT1325739E (de) |
| WO (1) | WO2002030397A1 (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7968569B2 (en) * | 2002-05-17 | 2011-06-28 | Celgene Corporation | Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| AU2004218090A1 (en) * | 2003-03-04 | 2004-09-16 | Sosei Co., Ltd. | GM-95-containing antitumor effect potentiator, combined antitumor preparation and antitumor agent |
| JPWO2005021012A1 (ja) * | 2003-08-29 | 2006-10-26 | テルモ株式会社 | ゲムシタビン封入薬剤担体 |
| EP1708752B1 (de) * | 2004-01-27 | 2012-02-22 | University Of Southern California | Therapeutisches krebsmittel mit polymergebundenem antikörper |
| CA2564542C (en) | 2004-04-22 | 2012-11-27 | Celator Pharmaceuticals, Inc. | Combination formulations of anthracycline agents and cytidine analogs |
| ES2293753B1 (es) * | 2004-04-28 | 2009-03-16 | Lipotec, S.A. | Uso de peptidos xikvav en preparacion de composiciones cosmeticas para mejorar la firmeza de la piel mediante el aumento de la adhesion celular. |
| CN100438855C (zh) * | 2006-01-19 | 2008-12-03 | 浙江大学 | 重酒石酸长春瑞滨脂质体及其冻干粉针与制备方法 |
| CN101209243B (zh) * | 2006-12-29 | 2010-12-08 | 石药集团中奇制药技术（石家庄）有限公司 | 一种脂质体药物及其制备方法 |
| JP4966084B2 (ja) | 2007-04-25 | 2012-07-04 | エスアイアイ・プリンテック株式会社 | インクジェットヘッドの駆動方法、インクジェットヘッドおよびインクジェット記録装置 |
| US8067432B2 (en) * | 2008-03-31 | 2011-11-29 | University Of Kentucky Research Foundation | Liposomal, ring-opened camptothecins with prolonged, site-specific delivery of active drug to solid tumors |
| WO2010135714A2 (en) | 2009-05-22 | 2010-11-25 | The Methodist Hospital Research Institute | Methods for modulating adipocyte expression using microrna compositions |
| CN103083239B (zh) | 2012-12-26 | 2015-11-25 | 中国人民解放军第四军医大学 | 一种蟾毒灵脂质体及其制备方法和应用 |
| US9895313B2 (en) | 2015-03-03 | 2018-02-20 | Cureport, Inc. | Combination liposomal pharmaceutical formulations |
| WO2016141161A1 (en) | 2015-03-03 | 2016-09-09 | Cureport, Inc. | Dual loaded liposomal pharmaceutical formulations |
| CN106955271A (zh) * | 2016-01-08 | 2017-07-18 | 佛山英特医药科技有限公司 | 奥沙利铂聚集体及其制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0153955A1 (de) | 1983-09-06 | 1985-09-11 | Health Research, Inc. | Verfahren zum verabreichen von liposomen zum herabsetzen der toxizität eines antitumor-arzneimittels |
| EP0211042A1 (de) * | 1985-01-18 | 1987-02-25 | Cooper-Lipotech, Inc. | Liposomenzusammensetzungen und verfahren |
| US4797285A (en) | 1985-12-06 | 1989-01-10 | Yissum Research And Development Company Of The Hebrew University Of Jerusalem | Lipsome/anthraquinone drug composition and method |
| CA2088975A1 (en) | 1990-08-08 | 1992-02-09 | Anthony H. Huang | Stable doxorubicin/liposome composition |
| ES2072223B1 (es) | 1993-11-25 | 1996-03-16 | Lipotec Sa | Liposomas encapsulando doxorubicina. |
| US6071532A (en) * | 1996-10-15 | 2000-06-06 | Emory University | Synthesis of glycophospholipid and peptide-phospholipid conjugates and uses thereof |
-
2000
- 2000-10-10 ES ES200002447A patent/ES2186484B1/es not_active Expired - Fee Related
-
2001
- 2001-10-03 BR BR0113552-0A patent/BR0113552A/pt not_active IP Right Cessation
- 2001-10-03 AU AU9190401A patent/AU9190401A/xx active Pending
- 2001-10-03 JP JP2002533840A patent/JP4286535B2/ja not_active Expired - Fee Related
- 2001-10-03 EP EP01972111A patent/EP1325739B1/de not_active Expired - Lifetime
- 2001-10-03 PT PT01972111T patent/PT1325739E/pt unknown
- 2001-10-03 ES ES01972111T patent/ES2259674T3/es not_active Expired - Lifetime
- 2001-10-03 CA CA2425271A patent/CA2425271C/en not_active Expired - Fee Related
- 2001-10-03 US US10/398,627 patent/US7153490B2/en not_active Expired - Fee Related
- 2001-10-03 DE DE60117583T patent/DE60117583T2/de not_active Expired - Lifetime
- 2001-10-03 AT AT01972111T patent/ATE318582T1/de active
- 2001-10-03 MX MXPA03003125A patent/MXPA03003125A/es active IP Right Grant
- 2001-10-03 WO PCT/ES2001/000367 patent/WO2002030397A1/es not_active Ceased
- 2001-10-03 DK DK01972111T patent/DK1325739T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2425271A1 (en) | 2003-04-08 |
| CA2425271C (en) | 2011-04-19 |
| AU9190401A (en) | 2002-04-22 |
| US20050100590A1 (en) | 2005-05-12 |
| US7153490B2 (en) | 2006-12-26 |
| JP2004510811A (ja) | 2004-04-08 |
| ES2259674T3 (es) | 2006-10-16 |
| ATE318582T1 (de) | 2006-03-15 |
| WO2002030397A9 (es) | 2004-05-13 |
| EP1325739A1 (de) | 2003-07-09 |
| PT1325739E (pt) | 2006-07-31 |
| AU2001291904B2 (en) | 2006-05-11 |
| ES2186484B1 (es) | 2004-07-01 |
| BR0113552A (pt) | 2003-07-29 |
| ES2186484A1 (es) | 2003-05-01 |
| WO2002030397A1 (es) | 2002-04-18 |
| JP4286535B2 (ja) | 2009-07-01 |
| MXPA03003125A (es) | 2004-05-04 |
| DK1325739T3 (da) | 2006-07-10 |
| DE60117583T2 (de) | 2006-10-05 |
| EP1325739B1 (de) | 2006-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60117583D1 (de) | Liposomen welche antikanzeröse wirkstoffe verkapseln und deren verwendung zur behandlung von malignen tumoren | |
| DE69923675D1 (de) | Pharmazeutische trägervorrichtung welche zur verabreichung von wirkstoffen an schleimhautoberflächen geeignet ist | |
| CY1107838T1 (el) | Παραγωγα αδαμαντανιου για τη θεραπεια φλεγμονωδων, ανοσολογικων και καρδιαγγειακων ασθενειων | |
| ATE216220T1 (de) | Osmotische darreichungsform mit zwei mantelschichten | |
| DE60321929D1 (de) | Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen | |
| ATE232100T1 (de) | Gegen magensaft geschützte omeprazol- mikrogranülen, herstellungsverfahren und pharmazeutische zubereitungen | |
| CO4290346A1 (es) | Formas de dosificacion de liberacion controlada de azitromicina | |
| ATE514418T1 (de) | Rasch zerfallende feste darreichungsformen mit nichtbröseliger konsistenz und pullulan | |
| DE69433818D1 (de) | Kombinierte wirkstoffe als methode zur gezielten wirkstoff-freisetzung | |
| NO20032027D0 (no) | Effektive antitumorbehandlinger | |
| DE69822496D1 (de) | Lipidkomplex-lyophilisat von wasserunlöslichen porphyrinen | |
| CY1110329T1 (el) | Πεγκυλιωμενη λιποσωμιακη δοξορουβικινη σε συνδυασμο με εκτεϊνασκιδινη 743 | |
| DE69426334D1 (de) | Parenterales Busulfan zur Behandlung von malignen Krankheiten | |
| DE69815094D1 (de) | 2-(iminoethyl)-aminophenyl - derivate, deren herstellung, deren verwendung als medikamente und diese enthaltende pharmazeutische zubereitungen | |
| ATE275966T1 (de) | Activin stimulator enthaltende pharmazeutische zusammensetzung | |
| DE59005281D1 (de) | Pharmazeutische präparate. | |
| DE69700983D1 (de) | Ligandgerichtete enzyme-prodrug therapie | |
| PL368686A1 (en) | Novel aminobenzoephenones | |
| DE50008032D1 (de) | Pharmazeutische zusammensetzung aus spinnengiften sowie deren herstellung und verwendung zur behandlung von tumorerkrankungen | |
| ATE414100T1 (de) | Zielgerichtete ligande gegen peyer's flecke- und/oder m-zellen | |
| HRP20080597T3 (en) | Cancer combination therapy comprising azd2171 and zd1839 | |
| EA200100311A1 (ru) | Бифункциональные антитела и их применение для прицельной доставки противоопухолевых средств | |
| TR200000728T2 (tr) | Kronik hepatit C' nin tedavisinde IFN-alfa ve amantadin kullanımı. | |
| AR109456A2 (es) | Uso de et743 para la preparación de un medicamento para el tratamiento de un paciente humano afectado por cáncer mediante terapia de combinación | |
| RU2003114803A (ru) | Способ тканевой терапии хронических заболеваний желудка |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8327 | Change in the person/name/address of the patent owner |
Owner name: GP PHARM S.A., BARCELONA, ES |